Hormone Replacement Therapy in Postmenopausal Women With Diabetes Mellitus: A Risk-Benefit Assessment

ISSN： 1170-229X

Source： Drugs & Aging, Vol.17, Iss.5, 2000-11, pp. : 399-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus

By Howlett H.C.S.

Drug Safety, Vol. 20, Iss. 6, 1999-06 ,pp. : 489-503

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus

By Gallwitz Baptist

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 87-100

Adis International

Access to resources Recommend Favorite

Hormone replacement therapy (HRT) with drospirenone offers the additional benefit of blood pressure reduction in postmenopausal women

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 24, Iss. 2, 2008-02 ,pp. : 12-14

Adis International

Access to resources Recommend Favorite

Cardiovascular Disease Risk and Hormone Replacement Therapy (HRT): A Review Based on Randomised, Controlled Studies in Postmenopausal Women

Current Medicinal Chemistry, Vol. 7, Iss. 5, 2000-05 ,pp. : 499-517

Bentham Science Publishers

Access to resources Recommend Favorite

EFFECTS OF HORMONE REPLACEMENT THERAPY ON LIPID PEROXIDES AND OXIDATION SYSTEM IN POSTMENOPAUSAL WOMEN

By Akcay Tulay Dincer Yildiz Kayali Refik Colgar Umur Oral Engrin Cakatay Ufuk

Journal of Toxicology and Environmental Health, Vol. 59, Iss. 1, 2000-01 ,pp. : 1-5

Taylor & Francis Ltd

Access to resources Recommend Favorite